PRLD vs XRAY · rev $6.5M vs rev $3.68B
Prelude Therapeutics Inc (PRLD) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
PRLD currently screens at market cap $346.5M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PRLD and XRAY stock pages for the full models.
Not investment advice.